|  Help  |  About  |  Contact Us

Publication : Biochemical defect of the hph-1 mouse mutant is a deficiency in GTP-cyclohydrolase activity.

First Author  McDonald JD Year  1988
Journal  J Neurochem Volume  50
Issue  2 Pages  655-7
PubMed ID  3335865 Mgi Jnum  J:8982
Mgi Id  MGI:57446 Doi  10.1111/j.1471-4159.1988.tb02961.x
Citation  McDonald JD, et al. (1988) Biochemical defect of the hph-1 mouse mutant is a deficiency in GTP-cyclohydrolase activity. J Neurochem 50(2):655-7
abstractText  A hyperphenylalaninemic mouse mutant, hph-1, has been identified in the progeny of mice treated with the mutagen ethylnitrosourea. Phenylalanine hydroxylase activity levels in mutant liver lysates are reduced relative to normal, but correction for the amount of enzyme protein present demonstrates that the specific activity of this enzyme is normal in mutant mice. Quinonoid-dihydropteridine reductase activity is also normal. GTP-cyclohydrolase activity levels are essentially absent early in life and greatly diminished later in life. This finding has significant implications for the study of catecholamine neurotransmitter synthesis because GTP-cyclohydrolase catalyzes an important step in the de novo synthesis of tetrahydrobiopterin, an enzyme cofactor required for the synthesis of 3,4-dihydroxyphenylalanine (DOPA) and serotonin.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression